About this trial
Primary caregivers of patients diagnosed with idiopathic Parkinson's disease will be included in the study. A total of 43 participants will be recruited. At the beginning of the study, demographic data and clinical characteristics of the patients, including disease stage, history of falls, presence of fractures, presence and severity of pain, comorbidities, and medication use, will be recorded.
Subsequently, caregivers' age, gender, occupation, relationship to the patient, caregiving duration, and their own comorbidities will be assessed. Sleep problems will be evaluated using the Insomnia Severity Index (ISI), while symptoms related to depression and anxiety will be assessed with the Hospital Anxiety and Depression Scale (HADS). Caregiver burden will be examined using the Zarit Caregiver Burden Scale.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age between 40-80 years
Diagnosed with Parkinson's disease, Hoehn and Yahr stage 2-5
Requires assistance in daily activities
Informal caregiver providing care (unpaid, typically a family member such as a spouse or child)
Disqualifiers
Presence of any additional neurodegenerative disease other than Parkinson's disease
Diagnosis of Chronic Obstructive Pulmonary Disease (COPD)
Advanced heart failure classified as New York Heart Association (NYHA) Class IV (symptoms at rest)
Active cancer disease
Trial population
The study population will consist of caregivers of patients diagnosed with Parkinson's disease, aged between 40-80 years, who meet the inclusion criteria.
Trial design
Case-only
Cross-sectional
Treatments tested in this trial
- Other intervention
Treatment groups
Trial outcomes
Primary outcomes
Zarit Caregiver Burden Scale
A scale used to assess the physical, emotional, and social burden of caregiving, with higher scores indicating greater caregiver burden. Score range: 0-88.
Secondary outcomes
Insomnia Severity Index (ISI)
A scale used to evaluate the severity of sleep problems in caregivers, with higher scores reflecting more severe insomnia. Score range: 0-28.
Hospital Anxiety and Depression Scale (HADS)- Anxiety score
A tool used to assess symptoms of anxiety in caregivers. Higher scores indicate more severe anxiety. Score range: 0-21.
Hoehn and Yahr Scale
A classification system used to determine the disease stage of Parkinson's disease, with higher stages indicating more severe disease progression. Score range: 1-5.
Visual Analog Scale (VAS)
A linear scale used to assess pain severity, where higher scores indicate more severe pain. Score range: 0-10.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.